TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Notable Labs Stock

Notable Labs Stock

notablelabs.comHealthcare / Other HealthcareFounded: 2014Funding to Date: $62.12MM

Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process.

Buy or sell Notable Labs stockLearn more about Notable Labs IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Notable Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Notable Labs’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Notable Labs.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Matthew De Silva
Co-Founder, Chief Executive Officer & Board Member
Scott Patterson
Vice President of Engineering
Peter Quinzio
Co-Founder, Chief Financial Officer & and Board Member
Diane Heiser Ph.D
Chief Technology Officer & Scientific Co-Founder
Hiroomi Tada Ph.D
Chief Medical Officer
Michael Horowitz
Chief Operating Officer & General Counsel
Lloyd MacKenzie
Chief Development Officer

Board Members

Matthew De Silva
Peter Quinzio
Jim Kim
Builders VC

Frequently Asked Questions About Notable Labs’ Stock

plusminus
Can you buy Notable Labs’ stock?
Notable Labs is not publicly traded on NYSE or NASDAQ in the U.S. To buy Notable Labs’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Notable Labs’ stock?
Yes, you can sell stock of a private company like Notable Labs. Forge can help you sell your Notable Labs stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Notable Labs’ stock price?
Notable Labs is a privately held company and therefore does not have a public stock price. However, you may access Notable Labs’ private market stock price with Forge Data.
plusminus
What is Notable Labs’ stock ticker symbol?
Notable Labs does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Notable Labs in the Other Healthcare sector

Phil

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$300.91MM

Insightec

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$500MM

Blink Health

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$1.26B

Selkirk Pharma

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.45B

Zephyr AI

Sector
Healthcare / Other Healthcare
 
 

Parallel

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.47B

Reven Pharmaceuticals

Sector
Healthcare / Other Healthcare
 
 

Nutrafol

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$150MM

Lumicell

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$315.94MM

News Highlights

Pulse 2.0 07/22/2019
Personalized Oncology Company Notable Announces $40 Million Funding Round
Notable -- a company redefining cancer treatment with a clinically validated platform -- announced it raised $40 million in Series B.
Fierce Biotech 02/26/2019
Notable Labs brings on 2 development executives ahead of its first blood cancer trials
After launching its first in-house R&D program last month, cancer drug-testing startup Notable Labs has brought on two biopharma executives to take charge of its clinical operations and drug development work.

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.